CASI Pharmaceuticals, Inc. (CASIF) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$20.7M

Net Income/Loss (FY2025)

-$48.1M

Total Assets (FY2025)

$25.6M

Total Equity (FY2025)

-$59.6M

Cash Flows from Operating Activities (FY2025)

-$20.8M

Source: CASI Pharmaceuticals, Inc. 20-F filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.